BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38169463)

  • 1. Community-acquired bacterial pneumonia in children: an update on antibiotic duration and immunization strategies.
    Lyon E; Olarte L
    Curr Opin Pediatr; 2024 Apr; 36(2):144-149. PubMed ID: 38169463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current interest of antipneumococcal vaccination].
    del Rey Calero J
    An R Acad Nac Med (Madr); 2000; 117(1):163-78; discussion 178-83. PubMed ID: 11209555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community acquired pneumonia in children.
    Haq IJ; Battersby AC; Eastham K; McKean M
    BMJ; 2017 Mar; 356():j686. PubMed ID: 28255071
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries--a review.
    Falade AG; Ayede AI
    Afr J Med Med Sci; 2011 Dec; 40(4):293-308. PubMed ID: 22783679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults.
    Hedlund J; Strålin K; Ortqvist A; Holmberg H;
    Scand J Infect Dis; 2005; 37(11-12):791-805. PubMed ID: 16358446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia.
    Andrews J; Nadjm B; Gant V; Shetty N
    Curr Opin Pulm Med; 2003 May; 9(3):175-80. PubMed ID: 12682561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in the prevention and management of community-acquired pneumonia.
    Postma DF; van Werkhoven CH; Huijts SM; Bolkenbaas M; Oosterheert JJ; Bonten MJ
    Neth J Med; 2012 Oct; 70(8):337-48. PubMed ID: 23065981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of community acquired pneumonia].
    Welte T
    Internist (Berl); 2007 May; 48(5):476, 478-80, 482-4 passim. PubMed ID: 17431572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
    Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
    Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of community-acquired pneumonia in North American adults.
    File TM; Marrie TJ
    Postgrad Med; 2010 Mar; 122(2):130-41. PubMed ID: 20203464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.
    van Werkhoven CH; Bolkenbaas M; Huijts SM; Verheij TJM; Bonten MJM
    Clin Microbiol Infect; 2021 Jul; 27(7):995-999. PubMed ID: 32971253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ambulatory management of community-acquired pneumonia in the adult. II: Therapeutic strategy and follow-up].
    Lamy O
    Praxis (Bern 1994); 2002 Nov; 91(45):1915-20. PubMed ID: 12462894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.
    Isturiz R; Webber C
    Hum Vaccin Immunother; 2015; 11(7):1825-7. PubMed ID: 26076136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial community-acquired pneumonia in children: changes in causative agents.
    Korppi M; Heiskanen-Kosma T
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):132-6. PubMed ID: 11499302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.
    Krueger P; St Amant O; Loeb M
    BMC Geriatr; 2010 Jun; 10():44. PubMed ID: 20591180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia in children.
    Sinaniotis CA; Sinaniotis AC
    Curr Opin Pulm Med; 2005 May; 11(3):218-25. PubMed ID: 15818183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
    Principi N; Esposito S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.